Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2015Drug Testing and Analysis

Metabolic characterization of AH‐7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation

View Full Paper
Ask AI
Bookmark
Share

Authors

AWAriane WohlfarthCentral Forensic Science LaboratoryKSKarl B. ScheidweilerPomona CollegeSPShaokun PangCañada College

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wohlfarth et al. (2015) studied this question.

synapsesocial.com/papers/6a86ed7248ef9afcd2a24d8dhttps://doi.org/10.1002/dta.1856
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Fatality Involving AH-79212014 · 96 citations
  2. 2Determination of receptors that mediate opiate side effects in the mouse1983 · 82 citations
  3. 3An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion2008 · 138 citations
  4. 4Determination of Morphine, Morphine-3-glucuronide, and Morphine-6-glucuronide in Plasma after Intravenous and Intrathecal Morphine Administration Using HPLC with Electrospray Ionization and Tandem Mass Spectrometry1999 · 53 citations